GOAL viste, at der var flere patienter i behandling med Viani, der opnåede astmakontrol, end i gruppen, der kun fik inhalationssteroid og med en mindre dosis inhalationssteroid.
GOAL showed more patients treated with Viani achieved asthma control than patients treated with ICS alone and this control was attained at a lower corticosteroid dose.